Point72 Asset Management, L.P.
Position in CLDX — Celldex Therapeutics, Inc.
CIK 1603466
STAMFORD, CT
Position in CLDX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,361,644
-$98,092,021 QoQ
Shares Held
117,217
-96.4% QoQ
Ownership
0.149%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#75
of 252 holders
Holding Since
Mar 2021
17 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in CLDX Over Time
Shares Held
Position Value (USD)
Derivatives in CLDX
reported options exposure · as of Jun 30, 2026CallValue
$44,652
CallShares
1,200
PutValue
$37,210
PutShares
1,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Point72 Asset Management, L.P. holds $2,243,264,515 across 171 Biotechnology names. CLDX ranks #83 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
4,473,478 | $158,316,386 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,587,712 | $135,257,185 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,525,782 | $113,640,243 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
416,516 | $101,950,621 | |
| 5 | LEGN |
Legend Biotech Corp
|
3,076,124 | $88,838,461 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
137,029 | $73,577,721 | |
| 7 | CELC |
Celcuity Inc.
|
650,916 | $68,098,831 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
2,433,168 | $61,559,150 |
All Filings in CLDX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $44,652 | 1,200 | Call | Defined | 2026-08-14 | |
| 2026-06-30 | $4,361,644 | 117,217 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $37,210 | 1,000 | Put | Defined | 2026-08-14 | |
| 2026-03-31 | $102,453,665 | 3,229,939 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $47,756,976 | 1,758,357 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $100,736,279 | 3,893,942 | Shares | Defined | 2025-11-14 | |
| 2025-07-02 | $98,707,884 | 4,464,400 | Shares | Sole | 2025-07-10 | |
| 2025-06-30 | $57,015,022 | 2,801,721 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $47,574,326 | 2,621,175 | Shares | Defined | 2025-07-21 | |
| 2024-12-31 | $63,578,612 | 2,515,972 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $3,399,000 | 100,000 | Call | Defined | 2024-11-14 | |
| 2024-09-30 | $53,320,384 | 1,568,708 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $71,725,046 | 1,937,991 | Shares | Defined | 2024-09-16 | |
| 2024-03-31 | $53,880,960 | 1,283,797 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $109,307,798 | 2,756,122 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $36,942,848 | 1,342,400 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $40,200,264 | 1,184,800 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $8,257,517 | 229,503 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $22,543,506 | 505,800 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $3,794,850 | 135,000 | Shares | Defined | 2022-11-14 | |
| 2021-03-31 | $949,660 | 46,100 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||